{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:22:28Z","timestamp":1789906948189,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejmech.2024.116691","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T15:39:11Z","timestamp":1721489951000},"page":"116691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis"],"prefix":"10.1016","volume":"276","author":[{"given":"Marilia","family":"Barreca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Renda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Span\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Montalbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Valeria","family":"Raimondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bivacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Bandiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J.V.","family":"Galietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1415-6594","authenticated-orcid":false,"given":"Paola","family":"Barraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116691_bib1","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.ejmech.2024.116691_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cgh.2012.11.006","article-title":"Gastrointestinal complications of cystic fibrosis","volume":"11","author":"Gelfond","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2024.116691_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMra1300109","article-title":"Origins of cystic fibrosis lung disease","volume":"372","author":"Stoltz","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2024.116691_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cell.2017.02.024","article-title":"Molecular structure of the human CFTR ion channel","volume":"169","author":"Liu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2024.116691_bib5","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","article-title":"CFTR Modulators: the changing face of cystic fibrosis in the era of precision medicine","volume":"10","author":"Lopes-Pacheco","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116691_bib6","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1128\/MCB.25.12.5242-5252.2005","article-title":"Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin","volume":"25","author":"Farinha","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2024.116691_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.cell.2011.11.024","article-title":"Correction of both NBD1 energetics and domain interface is required to restore \u0394f508 CFTR folding and function","volume":"148","author":"Rabeh","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2024.116691_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cell.2011.11.023","article-title":"Requirements for efficient correction of \u0394F508 CFTR revealed by analyses of evolved sequences","volume":"148","author":"Mendoza","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2024.116691_bib9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ejmech.2019.07.037","article-title":"An overview on chemical structures as \u0394F508-CFTR correctors","volume":"180","author":"Span\u00f2","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116691_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112631","article-title":"Current development of CFTR potentiators in the last decade","volume":"204","author":"Span\u00f2","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116691_bib11","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2024.116691_bib12","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445\u2013Tezacaftor\u2013Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2024.116691_bib13","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2024.116691_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jcf.2011.12.005","article-title":"Ivacaftor potentiation of multiple CFTR channels with gating mutations","volume":"11","author":"Yu","year":"2012","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejmech.2024.116691_bib15","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/s41591-018-0200-x","article-title":"Structure-guided combination therapy to potently improve the function of mutant CFTRs","volume":"24","author":"Veit","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2024.116691_bib16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2024.116691_bib17","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor\u2013Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del","volume":"377","author":"Taylor-Cousar","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2024.116691_bib18","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jcf.2019.12.009","article-title":"Towards next generation therapies for cystic fibrosis: folding, function and pharmacology of CFTR","volume":"19","author":"Bose","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejmech.2024.116691_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1152\/ajplung.00305.2013","article-title":"Trimethylangelicin promotes the functional rescue of mutant F508del CFTR protein in cystic fibrosis airway cells","volume":"307","author":"Favia","year":"2014","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"10.1016\/j.ejmech.2024.116691_bib20","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3390\/molecules26051275","article-title":"Evaluation of fused pyrrolothiazole systems as correctors of mutant CFTR protein","volume":"26","author":"Span\u00f2","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116691_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejmech.2019.07.025","article-title":"Furocoumarins as multi-target agents in the treatment of cystic fibrosis","volume":"180","author":"Carbone","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116691_bib22","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1021\/acs.jmedchem.6b00777","article-title":"Preclinical activity of new [1,2]oxazolo[5,4-e]isoindole derivatives in diffuse malignant peritoneal mesothelioma","volume":"59","author":"Span\u00f2","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116691_bib23","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/cmdc.201200296","article-title":"Synthesis and antiproliferative activity of the ring system [1,2]oxazolo[4,5-g]indole","volume":"7","author":"Barraja","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2024.116691_bib24","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/S0960-894X(03)00529-8","article-title":"Pyrrolo[2,3-h]quinolinones: synthesis and photochemotherapic activity","volume":"13","author":"Barraja","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116691_bib25","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.tet.2013.01.076","article-title":"Synthesis of the new oligopeptide pyrrole derivative isonetropsin and its one pyrrole unit analogue","volume":"69","author":"Montalbano","year":"2013","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2024.116691_bib26","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1038\/s41598-023-34440-0","article-title":"Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel","volume":"13","author":"Renda","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2024.116691_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejmech.2018.09.013","article-title":"Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors","volume":"158","author":"Gu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116691_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114399","article-title":"Insight on pyrimido[5,4-g]indolizine and pyrimido[4,5-c]pyrrolo[1,2-a]azepine systems as promising photosensitizers on malignant cells","volume":"237","author":"Barreca","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116691_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113778","article-title":"Discovery of quinazoline derivatives as a novel class of potent and in vivo efficacious LSD1 inhibitors by drug repurposing","volume":"225","author":"Li","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116691_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114946","article-title":"Pyrimidine derivatives with antitubercular activity","volume":"246","author":"Finger","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116691_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejmech.2016.07.051","article-title":"Synthesis and antiproliferative mechanism of action of pyrrolo[3\u2032,2\u2032:6,7]cyclohepta[1,2-d]pyrimidin-2-amines as singlet oxygen photosensitizers","volume":"123","author":"Span\u00f2","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116691_bib32","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1021\/acs.jmedchem.3c02374","article-title":"Synthetic approaches to the new drugs approved during 2022","volume":"67","author":"France","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116691_bib33","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c01122","article-title":"An update on the nitrogen heterocycle compositions and properties of U.S. FDA-approved Pharmaceuticals (2013 \u2212 2023)","author":"Marshall","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116691_bib34","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1016\/j.bmc.2010.04.080","article-title":"Synthesis of pyrrolo[3,2-h]quinolinones with good photochemotherapeutic activity and no DNA damage","volume":"18","author":"Barraja","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116691_bib35","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1113\/jphysiol.2005.096669","article-title":"Failure of cAMP agonists to activate rescued \u0394F508 CFTR in CFBE41o- airway epithelial monolayers","volume":"569","author":"Bebok","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejmech.2024.116691_bib36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0014-5793(01)02561-3","article-title":"Green fluorescent protein-based halide indicators with improved chloride and iodide affinities","volume":"499","author":"Galietta","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2024.116691_bib37","doi-asserted-by":"crossref","first-page":"C872","DOI":"10.1152\/ajpcell.00507.2010","article-title":"Rescue of the mutant CFTR chloride channel by pharmacological correctors and low temperature analyzed by gene expression profiling","volume":"301","author":"Sondo","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424005713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424005713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T16:49:23Z","timestamp":1730738963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424005713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":37,"alternative-id":["S0223523424005713"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116691","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116691"}}